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Background: People in low-income countries purchase a high proportion of antimicrobials from retail drug
shops, both with and without a prescription. Tanzania’s accredited drug dispensing outlet (ADDO) program
includes dispenser training, enforcement of standards, and the legal right to sell selected antimicrobials. We
assessed the role of ADDOs in facilitating access to antimicrobials.
Methods: We purposively chose four regions, randomly selected three districts and five wards per district. Study
methods included interviews at 1200 households regarding care-seeking for acute illness and knowledge about
antimicrobials; mystery shoppers visiting 306 ADDOs posing as a caregiver of a child with 1) pneumonia, 2) mild
acute respiratory infection (ARI), or 3) a runny nose and request for co-trimoxazole; and audits of antimicrobial
availability and prices at 84 public health facilities (PHFs) and 96 ADDOs.
Results: Four hundred sixty seven (76 %) members from 367 (77 %) households had recently sought care outside
the home for acute illness; 128 had purchased antimicrobials, of which 61 % had been recommended by a
doctor or nurse and 32 % by an ADDO dispenser. Only 29 % obtained the antimicrobial at a PHF, whereas, 48 %
purchased them at an ADDO. Most thought that ADDOs are convenient place for care, usually have needed
medicines, and have high quality services and products, contrasting with 66 % who reported dissatisfaction with
PHF waiting times and 56 % with medicine availability. One-third (34 %) of mystery shoppers presenting the mild
ARI scenario were inappropriately sold an antimicrobial and 85 % were sold one on request; encouragingly, 99 %
presenting a case of pneumonia received either an antimicrobial, referral to a trained provider, or request to
bring the child for examination. Overall, 63 and 60 % of the 15 tracer antimicrobials were in stock in ADDOs and
PHFs, respectively; ADDOs had significantly more antimicrobial formulations for children available (83 vs. 51 %).
Of 369 records of antimicrobial sales in 47 ADDOs, 63 % were dispensed on prescription.
Conclusion: ADDOs have increased access to antimicrobials in Tanzania. Community members see them as
integral to the health system. Antimicrobials are overused due to poor ADDO dispensing, poor PHF prescribing,
and inappropriate public demand. Multi-pronged interventions are needed to address all determinants.
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A recent World Health Organization (WHO) report
points out that “very high rates of resistance have been
observed in bacteria that cause common health-care
associated infections in all WHO regions” [1]. Factors
that contribute to antimicrobial resistance include un-
necessary overuse and under dosing of antimicrobials
[2]. In low- and middle-income countries, only 70 %
of pneumonia cases receive an appropriate antimicro-
bial and about half of all acute viral upper respiratory
tract infection and viral diarrhea cases receive anti-
microbials inappropriately [3].
In low-resource countries, consumers often seek
care and purchase medicines, including antimicrobials,
at small retail drug shops [4, 5]. In some rural settings,
up to 80 % of people seek care at such shops because
few licensed pharmacies or pharmacists exist outside
of cities [6, 7] Other reasons for drug shop popularity
include shorter waiting time, nearness to home,
and more reliable drug availability compared with
public health facilities (PHFs) [8]. In a review of
51 low- and middle-income countries the cost of
medicines accounted for 100 % of health care costs for
41 to 56 % of households; 40 % of poor households
used savings, borrowed money, or sold assets to pay
for care [9].
In Tanzania, medicines need to be purchased
whether they are obtained at public facilities or drug
shops, unless the patient has an exempt status, such as
the elderly. In the past, unaccredited medicine shops
were only allowed to sell over-the-counter drugs; anti-
microbials were either sold illegally by the shops or
accessed at health facilities where supply problems
persisted [10]. To address this situation, the Tanzania
government adopted the ADDO program, which was
piloted in Ruvuma region in 2003, as national policy.
The accredited drug dispensing outlet (ADDO) pro-
gram combines extensive training, business incentives,
authorization to dispense a limited list of antimicro-
bials and other medicines to treat common conditions,
regulatory enforcement of practice standards, and
efforts to affect customer demand [11]. After 10 years
of the program, Tanzania has about 9000 accredited
(or nearly accredited) shops distributed throughout
the country in all regions and districts, and over
19,000 trained dispensers. With a population of 45
million, this translates to approximately one ADDO
per 5000 people. Previous evaluations of the program
have shown that ADDOs have contributed to improve-
ments in the use of antimicrobials [12, 13].
In this study in 2013, we carried out a multi-
component assessment to determine how antimicrobials
are currently accessed and used in rural communities in
Tanzania, with a particular focus on the role of ADDOs.Methods
Sampling
We purposively selected four regions to be both logis-
tically feasible and to span the range of experience with
ADDOs. Morogoro represented the eastern regions and
had more than 5 years’ of experience in implementing
ADDOs; Tanga represented the northern regions and
had 2 years’ of experience of implementing ADDOs;
Mbeya represented the relatively high socioeconomic
status southern highland regions and had 2 to 3 years’
of experience in implementing ADDOs; and Singida
represented the relatively low socioeconomic status
central regions and had implemented ADDOs in 2008.
At the time of the study, Mbeya had 627 ADDOs,
Singida 139, Morogoro 658, and Tanga 274.
Once we selected the four regions, we developed a
two-stage cluster sample as recommended by WHO/
Medicines Transparency Alliance [14]. Within each
region sampled, three districts were randomly selected
with probability proportional to population size. A
complete list of wards and numbers of ADDOs was
compiled for each sampled district. High-density wards
included wards with five or more ADDOs, except in
Singida’s districts, where fewer ADDOs are registered,
so the high-density threshold was lowered to three or
more ADDOs. Low-density wards included all other
wards with ADDOs. Wards without a registered ADDO
were classified in a third category. From these lists, we
randomly selected two high-density wards, two low-
density wards, and one ward with no ADDOs with
probability proportional to the population size in each
sampled district, for a total of 60 wards.
All villages in the selected wards with ADDOs were
grouped into two strata: those close to an ADDO (within
5 km) or far from the ADDO (more than 5 km). In
wards without ADDOs, we grouped all villages into two
strata: within 5 km of the ward population center or
more than 5 km from the ward population center. We
gave each village a serial number that we used to
randomly select three villages from the first stratum and
one from the second.
We selected five households within each selected
village by numbering each household, dividing the
number of houses in the village by five and then divid-
ing the list into segments comprising that number of
households to obtain a sampling interval. A house was
selected randomly in the first segment using the last
two numbers of village chairperson’s cell phone num-
ber. The other four households in the village were
selected systematically from the list using the sampling
interval. If no one was available in the selected house-
hold, the team left a message with a neighbor to inform
them that the team would return later in the day. If the
interviewer still did not find the responsible person
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Household data collection
The survey of 1200 households characterized medicines
access, use, and antimicrobial resistance knowledge and
perceptions in the community. Interviewers selected the
respondent who was the most knowledgeable person
about the health of household members and their use of
medicines. They asked respondents whether anyone in
the household had an acute illness in the previous two
weeks; if so, we assessed their perception of the illness
severity and whether and where each person had sought
advice, care, and medicines for the illness. Interviewers
also examined the household’s stock of medicines and
asked respondents about their views on the quality of
service at ADDOs and PHFs and about their knowledge
of antimicrobials.
Mystery shoppers
To assess ADDO performance we conducted 306 mystery
shopper visits at ADDOs in the 60 wards. Using mystery
shoppers is a well-documented evaluation method [15]
that has been used successfully in Tanzanian ADDOs
before [12]. Members of the Tanzania Consumer Advo-
cacy Society from each region were trained to pose as a
parent or caregiver of a one-year-old child. To select
ADDOs for the sample, we used a similar randomization
process as for households; we listed all ADDOs in the
ward and chose the required number by systematic ran-
dom sampling.
Each ADDO received one visit from a mystery shop-
per acting out one of three scenarios (102 visits for each
scenario): pneumonia (child with cough, difficulty
breathing, and fast breathing with harsh noise); mild
ARI (child with cough and runny nose); mild ARI with a
request for an antimicrobial. For the first two scenarios,
mystery shoppers presented only symptoms and waited
for the ADDO dispenser’s response, while for the third
scenario, they described symptoms then explicitly re-
quested Septrin. Septrin© is a brand of cotrimoxazole
(sulfamethoxazole-trimethoprim) that is widely used
locally, so it was reasonable for shoppers to ask for it by
name. We chose co-trimoxazole because at that time, it
was the recommended drug for managing pneumonia,
and the ADDO dispensers had been trained in its use.
Facility audits
To examine availability and price of antimicrobials in
facilities, we randomly selected three ADDOs in each
high-density ward and one ADDO in each low-density
ward, for a total of 96 ADDOs. We also randomly
selected one to two PHFs (public hospitals, health cen-
ters, dispensaries) per high ADDO density ward, one perlow density ward, and one per ward with no ADDOs, for
a total of 84 PHFs. In each ADDO and PHF, we checked
drug stocks and selling prices for a tracer list of 15 anti-
microbials. The selection criteria for the tracer antimi-
crobials were inclusion on both the National Essential
Drug List and the authorized list of ADDO medicines.
They included different medicine formulations (tablets,
capsules, dry syrups, suspensions, and injectable) appro-
priate for child and adult illnesses. We calculated the
medicine price ratio (MPR) for each product by compar-
ing the customer price with the median supplier price in
the International Drug Price Indicator Guide 2012 [16].
We then compared the medians of these ratios for
ADDOs and PHFs.
Data analysis
The interviewers entered data for the household survey
directly onto preprogrammed tablets and downloaded
it to a database. Data from the three surveys were ana-
lyzed with Stata survey commands that use sampling
weights to adjust for the two-stage clustered sample
structure. Wards were considered the primary sampling
units for both facility and household surveys. The four
purposively selected regions were treated with equal
weights in calculating sample-wide estimates. Popula-
tion sampling weights were applied in the analysis of
the household surveys.
We present household survey data as percentage esti-
mates with 95 % confidence intervals, adjusted by house-
hold distance from the closest ADDO, as well as by
respondent’s age, gender, and level of education, where
appropriate. We analyzed household survey opinions
related to health care services delivery in three steps:
first, we organized responses into four groups each
representing a domain: ADDO services (eight questions),
services in public health care facilities (four questions),
ADDO services in relation to services in other facilities
(four questions), and affordability of medicines (two
questions) (Additional file 1: Annex 1 includes a table of
these domains). Second, we calculated the rotated
principal component factors for each set of questions
and generated factor scores representing each of the four
domains. Finally, we used univariate and multivariate
regression to test the predictive value of region of origin,
household size, and respondent’s gender, age, and level of
education on each domain score (Table 2 and Additional
file 1: Annex 2).
From the facility survey data, we calculated the avail-
ability of each antimicrobial in health care facilities, by
type of facility and region; availability is presented as
percentage estimates with 95 % confidence intervals.
The median price ratio (MPR) for each product was
calculated as the unit price charged compared to the
median supplier price listed in the International
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Guide 2012 [16]. We used Stata regression survey com-
mands to test the predictive value of region and type of
facility on antimicrobial MPRs. We also compared the
medians of antimicrobial MPRs between ADDOs and
PHFs with a paired t-test.
For the mystery shopper visits, we did not use a prob-
ability sample and did not weight the data. Comparison
of results across scenarios was performed with a chi-
square test. Our logistic regression analysis considered
mild ARI as the reference situation for comparison of
the ADDO dispensers’ behavior in handling the other
two scenarios.
Ethical clearance
We obtained ethical clearance for the study from the
Tanzanian Ministry of Health and Social Welfare’s
National Institute for Medical Research and the
Harvard Pilgrim Health Care Institutional Review
Board. Authorities for the selected regions and districts
granted permission for the study after being briefed by
the Pharmacy Council of Tanzania. We explained the
study to all household respondents, who signed con-
sent forms to verify their willingness to participate.
Results
Household survey
The research team interviewed representatives from
1185 households with 6384 members. Of these, 614
household members (10 %) from 489 households (41 %)
had suffered from an acute illness in the previous two
weeks. Of those, 467 (76 %) sought care outside the
home. The more severe the condition was perceived,Table 1 Sources of recommendations and medicines for recent acu
Percentage of all medicines obt
Source of recommendation Total n = 581 ADDO n = 26
Doctor/nurse 60.0 [52.9, 66.6] 29.4 [20.1, 40.
ADDO 30.9 [24.5, 38.2] 58.8 [49.1, 67.
Self/ household member/ friend/ other 9.1 [6.2, 13.2] 11.8 [7.3, 18.6
Percentage of antimicrobials ob
Source of recommendation Total n = 128 ADDO n = 62
Doctor/nurse 60.7 [47.1, 72.8] 25.6 [11.8, 46.
ADDO 32.3 [21.4, 45.4] 65.8 [45.1, 81.
Self/ household member/ friend/ other 7.1 [3.2, 15.0] 8.6 [3.6, 19.2]
Percentage of antimicrobials ob
Source of recommendation Mbeya n = 24 Morogoro n =
Doctor/nurse 29.0 [8.3, 64.9] 55.8 [14.3, 90.
ADDO 62.5 [28.8, 87.3] 44.2 [9.5, 85.7
Self/ household member/ friend/ other 8.5 [2.0, 29.4] 0
aADDO accredited drug dispensing outlet
bAll ADDO recommended antimicrobials were obtained from ADDOsthe more likely the sick individuals were to seek exter-
nal care, varying from 91 % of those who perceived
their symptoms as severe to 70 % of those who did not.
The most common reported symptoms or diagnoses
were malaria (51 %) and common cold (49 %), followed
by pain (17 %), thirst/sweating (17 %), and watery diar-
rhea (5 %).
The 467 people with an acute illness sought care in
545 locations; 238 (44 %) went to a public health center
or district hospital, 180 (33 %) went to an ADDO, and
106 (19 %) went to a private practitioner or mission/
nonprofit clinic. Of the 93 who went to an ADDO first,
28 (30 %) were referred to a public facility. The 467 indi-
viduals took a total of 581 medicines (Table 1 top), of
which 128 were antimicrobials; 23 % of sick individuals
took an antimicrobial. The majority of these antimicro-
bials were recommended by a doctor or nurse (61 %)
and 32 % were recommended at an ADDO (Table 1
middle). However, nearly half of antimicrobials taken
(48 %) were purchased at an ADDO, while only 29 % were
obtained from a public health facility. Of the antimicro-
bials purchased at ADDOs, 26 % were recommended by a
doctor or nurse, but this varied considerably by region
(Table 1 bottom): 5 % in Singida, 23 % in Tanga, 29 % in
Mbeya, and 56 % in Morogoro.
A majority of the 1185 respondents agreed that they
can trust both the medicine quality (67 %) in ADDOs
and the advice about treatment from the dispenser
(66 %) (Additional file 1: Annex 1). They also felt that
ADDOs have good quality of service (56 %), and usually
have the medicines (57 %) or specifically antimicrobials
(48 %) needed. This contrasted with their attitudes
towards public health facilities: although half (51 %) ofte illnesses as reported in the household survey
ained by location [95 % CI]
9 Public facility n = 184 Private/mission/ NGO facility/ other n = 128
7] 99.0 [95.4, 99.8] 78.6 [63.2, 88.7]
8] 0.3 [0.0, 2.6] 8.3 [3.3, 19.5]
] 0.7 [0.1, 5.0] 13.1 [6.0, 26.1]
tained by location [95 % CI]
Public facility n = 37 Private/mission/ NGO facility/ other n = 29
8] 100.0 [., .] 86.9 [60.9, 96.6]
8] -** 1.7 [0.2, 13.6]
- 11.3 [2.6, 37.9]
tained in ADDO/DLDBs by region (n = 62) [95 % CI]
9 Singida n = 14 Tanga n = 15
5] 5.1 [0.9, 23.8] 22.6 [7.8, 50.2]
] 83.4 [49.0, 96.3] 67.1 [45.2, 83.5]
11.5 [2.1, 44.4] 10.3 [2.5, 34.1]
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PHFs, most were dissatisfied with the waiting time
(66 %) or thought it likely that the medicines they
needed would not be in stock there (56 %).
Respondents from the Morogoro region were more
likely to have a positive opinion of ADDO services
(odds ratio: 1.61 [95 % confidence intervals: 1.24, 2.08],
p < 0.001) and to prefer ADDOs to other facilities than
those from other regions (1.38 [1.24, 1.53], p < 0.001)
(Table 2). Respondents living close to an ADDO were
also more likely to prefer ADDOs to other facilities
(1.12 [1.04, 1.24], p < 0.05). Men were more likely than
women to have a negative opinion about services in
public health facilities (0.82 [0.72, 0.92], p < 0.01). Fi-
nally, lower education was a strong predictor of positive
opinion about public health facilities (1.55 [1.36, 1.78],
p < 0.001) and ADDOS (1.31 [1.03, 1.66], p < 0.05), and
of negative opinion about medicines affordability (0.89
[0.82, 0.95], p < 0.01).
Although widely used, antimicrobials were not widely
known or understood. Only 400 (34 %) of the 1185
respondents were familiar with the Kiswahili term forTable 2 Predictors of summary factor scores of respondent opinion
Outcome










< 5 km (vs. 5 km and over) 844 1.13
[0.97,1.32
Household size (vs. median size)
< median household size 468 1.01
[0.86,1.18
>median household size 499 0.97
[0.83,1.12
Respondent
Male (vs. female) 583 1.08
[0.94,1.24
Age (vs. <25 years)
25-50 years 702 0.96
[0.73,1.25
> 50 years 386 1.01
[0.75,1.37




This table shows predictors of summary factor scores of respondent opinions about
healthcare facilities, and medicines affordability from multivariate logistic regression
* p < 0.10, ** p < 0.05, *** p < 0.01, **** p < 0.001“antimicrobial” and only 91 (8 %) could spontaneously
name one antimicrobial correctly. Slightly more respon-
dents (9 %) spontaneously named one incorrectly, while
most did not offer any name. Of the 400 respondents
who said they had heard of antimicrobials, 84 % thought
they were good for coughs and colds, 79 % for malaria,
68 % for diarrhea with or without blood, 63 % for pneu-
monia, 54 % for sexually transmitted diseases, and 46 %
for purulent earache.
Of 1185 households visited, 165 households (14 %)
had 215 packets of antimicrobials in their household
stock, a much higher number than the 128 antimicro-
bials needed to treat recent acute illnesses. Indeed,
respondents reported that 36 % of these antimicrobials
were for current treatment and 64 % had been left over
from a previous illness. Similar to reported treatment for
recent illness, 61 % of these antimicrobials were recom-
mended by a doctor or nurse and 21 % by an ADDO or
drug store dispenser. However, 53 % of the antimicro-
bials were purchased in ADDOs, 32 % came from
PHFs, and 15 % came from other sources (data not
shown). Overall, 97 % of the 215 different packets ofs about health services from multivariate logistic regressions
s odds ratios [95 % confidence intervals]
n Services in public
health facilities





1.13 [0.93,1.38] 1.38**** [1.24,1.53] 1.02 [0.94,1.11]
]
1.20* [0.97,1.48] 0.97 [0.86,1.09] 1.02 [0.93,1.12]
]
0.96 [0.78,1.17] 1.04 [0.91,1.19] 0.96 [0.88,1.05]
]
1.03 [0.86,1.23] 1.12** [1.01,1.24] 1.05 [0.98,1.12]
]
1.01 [0.81,1.26] 0.95 [0.83,1.09] 1.02 [0.94,1.11]
]
1.02 [0.87,1.19] 0.94 [0.84,1.06] 0.95 [0.87,1.05]
]
0.82*** [0.72,0.92] 1.02 [0.91,1.13] 0.96 [0.90,1.01]
]
0.81* [0.65,1.01] 1.05 [0.90,1.23] 0.93*
[0.85,1.01]
]
0.87 [0.70,1.08] 1.03 [0.88,1.20] 0.90*
[0.81,1.01]
]
1.55**** [1.36,1.78] 0.99 [0.88,1.10] 0.89***
[0.82,0.95]
health services delivered in ADDOs, in public healthcare facilities, in other
s
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essential medicines list.Mystery shoppers at ADDOs
The three scenarios presented by mystery shoppers
elicited distinctly different patterns of treatment by
ADDO dispensers. For the mild ARI scenario, 45 % of
attendants probed for danger signs, particularly about
the seriousness of the fever (25 %), 36 % asked about the
duration of the illness, and 17 % about the affordability
of the medicine. Only one in five attendants (22 %)
offered a diagnosis to the mystery shopper; 93 %
dispensed medicine (34 % antimicrobials) with 29 %
giving instructions on how to take the medicine.
In comparison, with the direct request for co-
trimoxazole, dispensers were half as likely to probe for
danger signs, almost 14 times as likely to dispense
antimicrobials, and less likely offer a diagnosis or give
reasons for dispensing the medicine or instructions on
how to use the medicines (Table 3).
For the pneumonia scenario, the dispenser was
almost six times as likely to offer a diagnosis and six
times as likely to tell the caretaker to go to a health
facility. He or she was more than twice as likely to
dispense antimicrobials, to give instructions on how to
take the medicine, and to advise the caretaker to look
for danger signs and to refer the child, but overall
much less likely to dispense a medicine that is not an
antimicrobial (p < 0.001) (Table 3).
In terms of antimicrobial treatment, 34 % of mystery
shoppers presenting a mild ARI were sold an anti-
microbial, compared with 85 % presenting the same
symptoms plus requesting an antimicrobial (Fig. 1). For
customers describing symptoms of pneumonia, 54 %
were sold an antimicrobial and 90 % were referred, half
with an antimicrobial dispensed as well and halfTable 3 Comparing ADDO dispenser behaviors by scenario during m
models
Odds ratio [9
Behavior of ADDO dispenser Antimicrobia
Probing for danger signs 0.51** [0.28,0
Giving a diagnosis 0.67 [0.33,1.3
Dispensing medicines 1.00 [0.33,3.0
Dispensing antimicrobial 13.67**** [6.
Giving reasons for dispensing medicine(s) 0.73 [0.41,1.3
Giving instructions on how to use medicine(s) 0.87 [0.60,1.2
Advising caregiver to watch for danger signs 0.34* [0.12,1
Instructing caregiver to go to the health facility 0.65 [0.26,1.6
Referring child to health facility or doctor 1.53 [0.80,2.9
aCompared to mild ARI scenario (n = 102) and adjusted for region
* p < 0.10, ** p < 0.05, *** p < 0.01, **** p < 0.001without. Only 1 % of mystery shoppers was neither
referred nor given an antimicrobial.
Antimicrobial availability and price in ADDOs and health
facilities
Availability of antimicrobials tended to be better in
ADDOs than in public health facilities, particularly for
pediatric suspensions and syrups (Table 4). The average
availability of antimicrobials was 63 % in ADDOs com-
pared with 60 % in PHFs, but for suspensions the aver-
age availability was 83 % in ADDOs and 51 % in PHFs.
Table 5 shows some regional differences, however. The
Morogoro ADDOs had 70 % of all antimicrobials avail-
able compared to the other regions (range 62–64 %);
whereas, Mbeya public health facilities had 67 % avail-
able compared to the other regions (range 57–60 %).
Mbeya and Morogoro ADDOs had 89 and 90 % of sus-
pensions available compared to the other regions’
76 % availability, while Mbeya PHFs had 62 % of sus-
pensions available and Singida had 42 % compared to
the other regions (50 and 53 %). None of the PHFs
had all the antimicrobials surveyed and 22 % had all
four suspensions available, whereas, 5 % of ADDOs
had all antimicrobials and 61 % had all four suspen-
sions (Table 4).
Table 4 shows the MPR for each individual antimicro-
bial and Table 6 shows the MPR for antimicrobials
overall which was in ADDOs 2.42, compared with 2.16
for PHFs, which indicated that antimicrobials were on
average 12 % more expensive in ADDOS than in PHFs.
For suspensions only, the price ratio compared to the
median reference price in ADDOs was 2.12 and 1.89 in
PHFs, again indicating that prices in ADDOs were about
12 % more expensive. However, there were regional
differences (Table 6 and Fig. 2); in Tanga, PHFs’ antimi-
crobials were 4 % more expensive than in ADDOs,
whereas, antimicrobials in ADDOs were 12 % moreystery shopper visits using multivariate logistic regression
5 % confidence intervals]










Fig. 1 Referrals to seek health care and antimicrobial sales during mystery shopper visits by scenario
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goro, and 30 % more in Mbeya. For suspensions, ADDOs
were 13 % less costly than they were in PHFs in Tanga
and 1 % less in Mbeya, but suspensions were 14 % more
expensive in Singida ADDOs and 60 % more in Moro-
goro ADDOs.
Detailed antimicrobial dispensing records were avail-
able in only 47 of the 94 ADDOs. In 233 instances of
antimicrobial dispensing in these ADDOs, 63 % of anti-
microbials were dispensed on prescription rather than
being recommended by the ADDO dispenser.
Discussion
From the household survey, we have seen that clinicians
were the main cadre to recommend antimicrobials, but
more antimicrobials were purchased at ADDOs than
PHFs. This suggests that people value the advice of pub-
lic sector health professionals, but buy their medicines
mostly at ADDOs either because of preference or supply
system failures at PHFs. Consumers largely see ADDOs
as convenient, well-stocked—especially with antimicro-
bials—and as having good quality advice and products.
This is true even though prices of tracer medicines aver-
aged 12 % more than in PHFs (although this varied by
region). Availability of antimicrobials was also better in
ADDOs, especially for children’s formulations. Given
that PHFs are intended to sell medicines procured
through public systems with minimal price mark-up, the
ability of ADDOs to be price-competitive is somewhat
surprising. The convenience of a local retail drug shop
and relative certainty of availability may outweigh the
time and cost of visiting a PHF for many people in the
community.
Overall, people in rural Tanzania clearly think of
ADDOs as part of their health system, with the mostpositive opinions expressed in Morogoro, where of the
four sample regions, ADDOs have been in operation for
the longest time. The private sector is an important
source of care for the poor in low- and middle-income
countries a review of data from 38 countries indicated
[17]. The current study is interesting because it showed
how the community combines its use of the public and
private sectors, which confirms an earlier study on
malaria treatment [13]; moreover, it confirms that the
accreditation program in Tanzania has succeeded in the
intent described in its development [10].
The findings from the mystery shopper ADDO en-
counters illustrated that antimicrobials are still overused
in the community; for example, ADDO dispensers nearly
always supplied an antimicrobial on direct request
(80 %), which is more than the 49 % an earlier investiga-
tion reported [18]. However, dispensers sell fewer anti-
microbials when customers ask for their opinion on the
same symptoms (34 %). This is an encouraging sign of
improvement since a 2008 assessment in which ADDO
dispensers sold antimicrobials to 76 % of caretakers of a
one year-old child with watery diarrhea [12]. Another
positive sign is that only 23 % of people with an acute
illness seeking care were dispensed an antimicrobial,
compared to an average of 36 % in five national house-
hold surveys in Africa [19]. What is the most reassuring
is that ADDO dispensers treated pneumonia symptoms
more seriously and appropriately, which is a consider-
able improvement over other studies’ results where dis-
pensers had little ability to manage respiratory conditions
appropriately [20]. The fact that dispensers sold the ma-
jority (63 %) of antimicrobials based on a PHF prescrip-
tion means that antimicrobial overuse is not just an
ADDO problem, but also a public health sector problem
that is exacerbated by gaps in consumer knowledge. Only
Table 4 Percent availability and median MPRs of different antimicrobials by type of health care facility
ADDOs n = 94 Public health care facilities n = 72 Private pharmacies n = 13
% Availability [95 % CI] Median MPR (25th,
75th percentiles)a, b
% Availability [95 % CI] Median MPR (25th,
75th percentiles)a, b
% Availability [95 % CI] Median MPR (25th,
75th percentiles)a
All antimicrobials 5.3 [2.2, 12.3] 0.0 [., .] 61.5 [31.0, 85.1]
All suspension formulations 60.6 [48.7, 71.4] 22.2 [13.4, 34.5] 76.9 [46.5, 92.8]
Amoxicillin trihydrate 250 mg caps 81.9 [72.6, 88.6] 2.25 (1.69, 2.70) 86.1 [74.9, 92.8] 1.69 (1.35, 2.70) 100.0 [., .] 1.69 (1.69, 2.36)
Amoxicillin trihydrate 125 mg/5 mL suspension 86.2 [77.0, 92.1] 1.96 (1.84, 2.45) 62.0 [49.2, 73.3] 1.84 (1.10, 2.45) 100.0 [., .] 1.84 (1.22, 2.45)
Co-trimoxazole 480 mg tablets 87.2 [78.9, 92.6] 2.65 (2.12, 3.19) 84.7 [73.9, 91.6] 1.86 (1.33, 2.65) 92.3 [59.7, 99.0] 2.65 (2.39, 2.65)
Co-trimoxazole 240 mg/5 mL suspension 89.4 [81.3, 94.2] 1.80 (1.80, 2.40) 60.6 [48.0, 71.9] 1.80 (1.13, 2.22) 92.3 [59.7, 99.0] 1.80 (1.20, 2.40)
Erythromycin 250 mg tablets 75.5 [64.8, 83.8] 1.59 (1.32, 1.59) 83.1 [69.7, 91.3] 1.30 (0.63, 1.59) 100.0 [., .] 1.59 (1.59, 1.59)
Erythromycin 125 mg/5 mL suspension 74.5 [63.2, 83.2] 1.33 (1.33, 1.67) 54.2 [41.4, 66.4] 1.33 (1.21, 1.73) 92.3 [59.7, 99.0] 1.33 (1.33, 1.50)
Metronidazole 200 mg tablets 90.4 [83.0, 94.8] 3.28 (2.95, 4.92) 93.1 [84.0, 97.2] 2.46 (1.64, 3.93) 92.3 [59.7, 99.0] 3.11 (1.97, 4.92)
Metronidazole 200 mg/5 mL suspension 80.9 [71.0, 87.9] 3.24 (2.43, 3.24) 29.2 [19.2, 41.7] 2.43 (1.70, 3.24) 92.3 [59.7, 99.0] 2.43 (2.19, 3.24)
Ampicillin 250 mg caps 29.8 [21.3, 40.0] 2.14 (1.60, 2.25) 7.0 [2.9, 16.0] 2.57 (1.60, 3.08) 69.2 [42.7, 87.2] 1.60 (1.28, 1.60)
Ciprofloxacin 500 mg tablets 36.2 [26.9, 46.6] 2.38 (1.59, 3.17) 76.4 [63.2, 85.9] 2.38 (1.59, 3.02) 100.0 [., .] 1.59 (1.59, 2.38)
Ampicillin/ cloxacillin 500 mg caps 31.9 [22.9, 42.5] Not available 23.6 [14.8, 35.5] Not available 100.0 [., .] Not available
Doxycycline 100 mg caps/tablets 60.6 [50.6, 69.8] 4.17 (3.33, 4.17) 86.1 [75.1, 92.7] 4.17 (2.08, 4.17) 100.0 [., .] 4.17 (2.08, 4.17)
Tetracycline 250 mg caps 28.3 [19.9, 38.4] 2.26 (2.26, 2.63) 8.3 [3.7, 17.8] 2.26 (0.90, 2.26) 92.3 [59.7, 99.0] 2.26 (2.03, 2.26)
Procaine penicillin fortified 4MU, powder for injection 52.1 [41.1, 63.0] 2.23 (1.78, 2.23) 62.5 [51.2, 72.6] 2.01 (0.72, 2.79) 76.9 [49.9, 91.8] 1.78 (1.56, 2.23)
Benzyl penicillin 5MU, powder for injection 44.7 [33.3, 56.6] 2.44 (2.19, 2.44) 88.9 [78.3, 94.7] 2.44 (1.22, 3.05) 84.6 [57.2, 95.8] 1.95 (1.71, 2.44)
This table shows the percent availability and median prices in relation to international reference prices of different antimicrobials by type of health care facility
a Median price ratio (MPR) = median unit price in outlets/International Drug Price Indicator Guide reference procurement price














Table 5 Average availability of all antimicrobials and of antimicrobial suspension formulations by facility type and region
ADDOs mean percent available (SD) Public health facilities mean percent available (SD)
All antimicrobials
All regions 63.26 % (20.03 %) 60.19 % (20.17 %)
Mbeya 62.22 % (18.09 %) 67.08 % (14.50 %)
Morogoro 70.28 % (12.74 %) 57.25 % (23.22 %)
Singida 56.81 % (27.55 %) 57.46 % (22.06 %)
Tanga 63.48 % (18.08 %) 60.00 % (19.27 %)
Suspension formulations
All regions 82.71 % (26.19 %) 51.04 % (36.68 %)
Mbeya 88.54 % (22.09 %) 62.50 % (30.28 %)
Morogoro 89.58 % (24.36 %) 50.00 % (37.50 %)
Singida 76.09 % (26.63 %) 41.67 % (44.25 %)
Tanga 76.09 % (29.66 %) 52.78 % (30.78 %)
Chalker et al. Antimicrobial Resistance and Infection Control  (2015) 4:33 Page 9 of 11one-third of household respondents said they had heard
of antimicrobials and most did not know about their
appropriate use.
This study has several limitations. Our four regions
may not represent the whole of Tanzania. The house-
hold survey depended on reporting that is subject to
recall bias. The ADDO dispensers may not have seen
mystery shoppers as normal customers and therefore
treated them differently. Our research would have been
stronger if we had compared prescribing practices for
similar patients between ADDOs and public health
facilities, but most ADDOs lack records on diagnoses
and prescribing. However, from the limited sample of
ADDO dispensing records examined, of which 63 % of
antimicrobials were dispensed on prescription, it is
likely that many dispensing habits of dispensers mirror
PHF prescriptions. Although all dispensers had received
ADDO training, some retail drug shops in our study re-
gions were awaiting official accreditation. Because house-
hold members could not reliably distinguish between
accredited shops and those awaiting accreditation, we
combined them under the “ADDO” label for analysis,
which may have underestimated the ADDOs’ positiveTable 6 Mean of antimicrobial MPRsa for antimicrobials in ADDOs a
All Antimicrobials
Region ADDO MPR PHF MPR Ratio ADDO to P
Mbeya 2.32 1.79 1.30
Morogoro 2.51 2.17 1.16
Singida 2.62 2.33 1.12
Tanga 2.25 2.33 0.96
All 2.42 2.16 1.12
a Median price ratio (MPR) = median unit price in outlets/International Drug Price Ind
This table shows the mean of medicine price ratios (MPRs) of all antimicrobials and
overall and by regioneffect. In the mystery shopper and price and availability
surveys, however, we only visited fully accredited shops.
Although most treatment advice appears to originate
from doctors and nurses, and they prescribed most of
the medicines dispensed in ADDOs, serious problems
remain. Community members know little about anti-
microbials and their recommended use. In addition,
ADDO dispensers readily sell antimicrobials on request
despite being trained not to do so and realizing that the
practice is incorrect [21].
Successful interventions to improve community use
of antimicrobials require a combination of approaches
targeting all stakeholders, including not only ADDO
dispensers but also community members, public
sector prescribers, and government regulators [22]. An
earlier study in Tanzania showed that a public aware-
ness campaign using posters, specific training of
ADDO dispensers, and education of public facility
staff improved the use of antimicrobials [23]. Interven-
tions in the private sector may be effective [24], in
particular changing incentives and accountability may
be the most effective way of changing behavior [25].
The WHO strongly recommends monitoringnd public health facilities
Suspensions






icator Guide reference procurement price. PHF = public health facilities
of antimicrobial pediatric formulations in ADDOs and public health facilities,
Fig. 2 Regional median of median price ratios MPRs* for antimicrobials in ADDOs and public health facilities
Chalker et al. Antimicrobial Resistance and Infection Control  (2015) 4:33 Page 10 of 11antimicrobial use as a way to control antimicrobial re-
sistance [26]. Initiating active supervision of anti-
microbial dispensing practices in ADDOs and linking
the results to accreditation status may comprise an ef-
fective strategy when coupled with similar monitoring
in PHFs and with public campaigns to counteract in-
adequate community knowledge of antimicrobials.Conclusion
Accredited drug dispensing outlets have increased rural
Tanzanian’s access to antimicrobials and are viewed as
an integral part of the health care system. Use of anti-
microbials remains suboptimal, however, but this stems
not only from poor dispensing practices in ADDOs, but
also from poor prescribing and antimicrobial availability
in public facilities as well as inappropriate consumer
demand rooted in poor understanding. To improve
how the community uses antimicrobials, multi-pronged
interventions to increase appropriate practices in both
ADDOs and public health facilities need to be combined
with active monitoring of those practices.Additional file
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